| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relay Therapeutics, Inc. (RLAY) has 7 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $23.03M | - | |
| Pres | 420.0K | $6.67M | - | |
| Other | 371.5K | $5.90M | - | |
| Other | 276.6K | $4.39M | - | |
| CFO | 215.7K | $3.42M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2020 | Patel Sanjiv74 | President And CEO | Buy | 25,000 | $20.00 | $500,000.00 | +6.6% | |
| Jul 20, 2020 | Adams Brian72 | General Counsel | Buy | 10,000 | $20.00 | $200,000.00 | New | |
| Jul 20, 2020 | Murcko Mark | Director | Buy | 25,000 | $20.00 | $500,000.00 | +2.5% | |
| Jul 20, 2020 | Rubin Jami | Director | Buy | 25,000 | $20.00 | $500,000.00 | New | |
| Jul 20, 2020 | Ingram Douglas S | Director | Buy | 25,000 | $20.00 | $500,000.00 | New |